CNCR : Loncar Cancer Immunotherapy ETF

CNCR is a Sector Equity Market Healthcare with MODERATE fees.

CNCR

Loncar Cancer Immunotherapy ETF

FI Score

39 /100

Diversification Rating

10 /10

Expense Ratio Rating

6 /10

Expense Rating

2 /10

Market Score

1 /10

Category Score

0 /10

Market Size

1 /10

Fees & Expenses

Fees Overview

Similar Funds 107 funds
Avegage Expense Ratio 1.07%
Expense ratio of CNCR 0.79%

This funds expense ratio fees of 0.79% are lower than other similar funds.

Other similar funds have an expense ratio fee of 1.07%.

Minafi - The intersection of FI, minimalism & mindfulness.

Don't miss out on new posts, courses, interactive articles and more!

Join & Get Your First Course Free

© 2024   Adam Fortuna

Site Map
Triangle Graduation Cap Angle Down Book regular Phone laptop regular fire regular fire regular search regular Acorn duotone Seedling duotone thumbs down duo thumbs up duo